Source: Eur Respir J 2002; 19: 684-689
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Kohyama T., Liu X.D., Wen F.Q., Kim H.J., Takizawa H., Rennard S.I.. Prostaglandin D2 inhibits fibroblast migration. Eur Respir J 2002; 19: 684-689

Member's Comments

No comment yet.

Related content which might interest you: The inducible kinin B1 receptor stimulates human airway fibroblast (Fb) proliferation Source: Eur Respir J 2004; 24: Suppl. 48, 37s Year: 2004 Fevipiprant inhibits eosinophil activation induced by multiple metabolites of prostaglandin D2 Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019 Bradykinin-induced fibroblast proliferation and myofibroblast differentiation via B2 receptor pathway Source: Eur Respir J 2005; 26: Suppl. 49, 342s Year: 2005 Lipoxin A4 promotes lung epithelial repair whilst inhibiting fibroblast proliferation Source: ERJ Open Res 2016: 00079-2015 Year: 2016 Activation of E-prostanoid4 and E-prostanoid2 receptors inhibits TNF-α release from human alveolar macrophages Source: Eur Respir J 2007; 29: 986-994 Year: 2007 Bronchoconstriction induced by prostaglandin D2 (PGD2) in guinea pig lung is enhanced by selective COX-2 inhibition Source: Eur Respir J 2006; 28: Suppl. 50, 759s Year: 2006 The PDE4-inhibitors roflumilast and rolipram modulate fibroblast collagen-gel contraction and chemotaxis mediated by autocrine PGE2 synthesis induced by TGF-β1 Source: Eur Respir J 2005; 26: Suppl. 49, 214s Year: 2005 Prostaglandin D2 is a human airway smooth muscle chemoattractant Source: Eur Respir J 2006; 28: Suppl. 50, 338s Year: 2006 COX-1 driven biosynthesis of PGD2 during activation of human mast cells prevents formation of other prostanoids Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes Year: 2020 Generation and activation of myeloid derived suppressor cells using prostaglandin E2 and EP receptor agonists in vitro Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 Antigen-induced formation of prostaglandin D2 in mouse asthma model Source: Eur Respir J 2005; 26: Suppl. 49, 578s Year: 2005 Inhibition of eosinophil migration by montelukast, a cysteinyl leukotriene receptor antagonist, through down regulation of plasmin activity Source: Eur Respir J 2004; 24: Suppl. 48, 36s Year: 2004 Mesothelioma cells counteract talc toxicity by prostaglandin E2 (PGE2) Source: Eur Respir J 2003; 22: Suppl. 45, 85s Year: 2003 VEGF induces ECM synthesis and fibroblast activity in human lung fibroblasts Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017 Prostaglandin D2 induces MUC5B gene expression via DP1 in human airway epithelial cells Source: Annual Congress 2010 - Lung cell biology and immunology Year: 2010 Prostaglandin E2 inhibits NLRP3 inflammasome activation through EP4 receptor and intracellular cAMP in human macrophages Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 Prostaglandin D2 and the role of the DP1, DP2 and TP receptors in the control of airway reflex events Source: Eur Respir J 2015; 45: 1108-1118 Year: 2015 Prostaglandin E2 suppresses the function of human group 2 innate lymphoid cells Source: International Congress 2018 – Roles of innate lymphoid cells in asthma Year: 2018 In vitro profibrotic effects of rapamycin on basal or TGF-β1 induced primary human lung fibroblast: ECM production and turnover, migration and differentiation Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Effect of bradykinin (BK) on human airway fibroblast (Fb) proliferation and myofibroblast (MyoFb) differentiation Source: Eur Respir J 2004; 24: Suppl. 48, 37s Year: 2004